PL1753764T3 - Pochodne pirolopirydyny - Google Patents

Pochodne pirolopirydyny

Info

Publication number: PL1753764T3
Authority: PL; Poland
Prior art keywords: pyrrolopyridine derivatives; pyrrolopyridine; derivatives
Prior art date: 2004-06-09

Application number

PL05747418T

Other languages

English (en)

Inventor

Andrew John Eatherton

Gerard Martin Paul Giblin

Matthew Russell Johnson

William Leonard Mitchell

Alcide Perboni

Brian Peter Slingsby

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-09

Filing date

2005-06-07

Publication date

2009-04-30

2004-06-09 Priority claimed from GB0412908A external-priority patent/GB0412908D0/en

2004-11-11 Priority claimed from GB0424950A external-priority patent/GB0424950D0/en

2005-06-07 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2009-04-30 Publication of PL1753764T3 publication Critical patent/PL1753764T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL05747418T 2004-06-09 2005-06-07 Pochodne pirolopirydyny PL1753764T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0412908A GB0412908D0 (en)	2004-06-09	2004-06-09	Compounds
GB0424950A GB0424950D0 (en)	2004-11-11	2004-11-11	Compounds
EP05747418A EP1753764B1 (en)	2004-06-09	2005-06-07	Pyrrolopyridine derivatives
PCT/EP2005/006182 WO2005121140A1 (en)	2004-06-09	2005-06-07	Pyrrolopyridine derivatives

Publications (1)

Publication Number	Publication Date
PL1753764T3 true PL1753764T3 (pl)	2009-04-30

Family

ID=34969264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05747418T PL1753764T3 (pl)	2004-06-09	2005-06-07	Pochodne pirolopirydyny

Country Status (25)

Country	Link
US (1)	US7589206B2 (pl)
EP (1)	EP1753764B1 (pl)
JP (1)	JP2008501758A (pl)
KR (1)	KR20070034049A (pl)
AR (1)	AR050158A1 (pl)
AT (1)	ATE412651T1 (pl)
AU (1)	AU2005251913A1 (pl)
BR (1)	BRPI0511874A (pl)
CA (1)	CA2569887A1 (pl)
DE (1)	DE602005010698D1 (pl)
DK (1)	DK1753764T3 (pl)
ES (1)	ES2317244T3 (pl)
HR (1)	HRP20090034T3 (pl)
IL (1)	IL179603A0 (pl)
MA (1)	MA28686B1 (pl)
MX (1)	MXPA06014471A (pl)
NO (1)	NO20070067L (pl)
PE (1)	PE20060430A1 (pl)
PL (1)	PL1753764T3 (pl)
PT (1)	PT1753764E (pl)
RU (1)	RU2006147278A (pl)
SI (1)	SI1753764T1 (pl)
TW (1)	TW200611695A (pl)
UY (1)	UY28945A1 (pl)
WO (1)	WO2005121140A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA06000795A (es)	2003-07-22	2006-08-23	Arena Pharm Inc	Derivados de diaril y arilheteroaril urea como moduladores del receptor 5-ht2a de serotonina utiles para la profilaxis y tratamiento de desordenes relacionados con el mismo.
PL1753764T3 (pl)	2004-06-09	2009-04-30	Glaxo Group Ltd	Pochodne pirolopirydyny
KR102152809B1 (ko) *	2004-07-28	2020-09-07	다케다 야쿠힌 고교 가부시키가이샤	피롤로〔2,3-ｃ〕피리딘 화합물, 그 제조 방법 및 용도
CA2579087C (en) *	2004-09-03	2012-05-01	Yuhan Corporation	Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
CA2618165A1 (en) *	2005-08-09	2007-02-15	Glaxo Group Limited	Imidazopyridine derivatives as cannabinoid receptor ligands
GB0516379D0 (en) *	2005-08-09	2005-09-14	Glaxo Group Ltd	Compounds
WO2007118041A1 (en) *	2006-04-07	2007-10-18	Boehringer Ingelheim International Gmbh	Compounds which modulate the cb2 receptor
WO2008113818A1 (en) *	2007-03-21	2008-09-25	Glaxo Group Limited	Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome
GB0705803D0 (en) *	2007-03-28	2007-05-02	Glaxo Group Ltd	Novel compounds
EP2508177A1 (en)	2007-12-12	2012-10-10	Glaxo Group Limited	Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
US20110021538A1 (en)	2008-04-02	2011-01-27	Arena Pharmaceuticals, Inc.	Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en)	2008-10-28	2010-06-03	Arena Pharmaceuticals, Inc.	Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
CA2757188A1 (en)	2009-03-30	2010-10-07	Astellas Pharma Inc.	Pyrimidine compound
TW201200518A (en) *	2010-03-10	2012-01-01	Kalypsys Inc	Heterocyclic inhibitors of histamine receptors for the treatment of disease
CN103038218B (zh)	2010-07-29	2016-04-13	安斯泰来制药株式会社	稠环吡啶化合物
JP6326563B2 (ja) *	2012-03-19	2018-05-23	アリエル−ユニバーシティーリサーチアンドデベロップメントカンパニーリミテッド	β−カリオフィレンとＣＢ２受容体アゴニストを用いた精神病の治療
AU2014302365B2 (en)	2013-06-26	2018-11-15	Abbvie Inc.	Primary carboxamides as BTK inhibitors
MX388281B (es)	2015-06-12	2025-03-11	Axovant Sciences Gmbh	Derivados de diaril y arilheteroaril urea como moduladores del receptor 5ht2a de serotonina útiles para la profilaxis y el tratamiento de un trastorno conductual del sueño rem.
HK1247555A1 (zh)	2015-07-15	2018-09-28	Axovant Sciences Gmbh	用於预防和治疗与神经变性疾病相关的幻觉的作为5-ht2a血清素受体的调节剂的二芳基脲和芳基杂芳基脲衍生物
AU2019389025B2 (en) *	2018-11-30	2025-07-24	Takeda Pharmaceutical Company Limited	TYK2 inhibitors and uses thereof
US11891394B1 (en)	2023-09-06	2024-02-06	King Faisal University	Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitors
US11858935B1 (en)	2023-09-06	2024-01-02	King Faisal University	Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0113245B1 (en) *	1982-12-29	1989-03-15	Kureha Kagaku Kogyo Kabushiki Kaisha	Cephalosporin derivatives
CA2031927A1 (en)	1989-12-27	1991-06-28	Imperial Oil Limited	Method for improving the activity maintenance of a plasma initiator
FI922347L (fi)	1990-01-05	1992-05-22	Pfizer	Azaoxindolderivat.
US5112820A (en) *	1990-03-05	1992-05-12	Sterling Drug Inc.	Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
GB9109246D0 (en)	1991-04-30	1991-06-19	Ici Plc	Nitrogen derivatives
DE4129603A1 (de)	1991-09-06	1993-03-11	Thomae Gmbh Dr K	Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
TW263504B (pl)	1991-10-03	1995-11-21	Pfizer
FR2692575B1 (fr)	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5468757A (en)	1994-01-31	1995-11-21	Eli Lilly And Company	6-azaindole thromboxane synthase inhibitors
ATE166353T1 (de)	1994-02-18	1998-06-15	Boehringer Ingelheim Pharma	2-heteroaryl-5,11-dihydro-6h-dipyrido(3,2-b:2', '-e> (1,4>diazepine und ihre verwendung zur vorbeugung und behandlung von hiv-infektion
GB9420521D0 (en)	1994-10-12	1994-11-30	Smithkline Beecham Plc	Novel compounds
US5589482A (en)	1994-12-14	1996-12-31	Pfizer Inc.	Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
JPH0920779A (ja)	1995-05-01	1997-01-21	Japan Tobacco Inc	縮合ヘテロ５員環アゼピン化合物類及びその医薬用途
GB9610811D0 (en)	1996-05-23	1996-07-31	Pharmacia Spa	Combinatorial solid phase synthesis of a library of indole derivatives
US6696448B2 (en)	1996-06-05	2004-02-24	Sugen, Inc.	3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
US6184235B1 (en)	1996-08-14	2001-02-06	Warner-Lambert Company	2-phenyl benzimidazole derivatives as MCP-1 antagonists
TWI242011B (en)	1997-03-31	2005-10-21	Eisai Co Ltd	1,4-substituted cyclic amine derivatives
JP2002511852A (ja)	1997-05-07	2002-04-16	スージェン・インコーポレーテッド	蛋白質キナーゼ活性の調節剤としての２−インドリノン誘導体
EP0931872B1 (de)	1998-01-23	2003-04-09	Voith Paper Patent GmbH	Verfahren zur Entfernung von feinen Verunreinigungen aus einer Faserstoffsuspension
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
WO2000012084A1 (en)	1998-08-31	2000-03-09	Sugen, Inc.	Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
GB9904995D0 (en)	1999-03-04	1999-04-28	Glaxo Group Ltd	Substituted aza-oxindole derivatives
JP2002538204A (ja)	1999-03-10	2002-11-12	メルクエンドカムパニーインコーポレーテッド	性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
EP1161431A4 (en)	1999-03-10	2002-04-24	Merck & Co Inc	6-AZAINDOL COMPOUNDS AS AN ANTAGONISTS OF THE GONADOTROPIN RELEASE HORMONES
JP2002538206A (ja)	1999-03-10	2002-11-12	メルクエンドカムパニーインコーポレーテッド	性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
JP2003526618A (ja)	1999-03-10	2003-09-09	メルクエンドカムパニーインコーポレーテッド	性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
WO2000053185A1 (en)	1999-03-10	2000-09-14	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
WO2000053180A1 (en)	1999-03-10	2000-09-14	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
CA2390948A1 (en)	1999-06-03	2000-12-14	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
HK1045306A1 (zh)	1999-06-03	2002-11-22	Abbott Laboratories	抑制细胞黏附的抗炎化合物
WO2001058869A2 (en)	2000-02-11	2001-08-16	Bristol-Myers Squibb Company	Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
US20020061892A1 (en)	2000-02-22	2002-05-23	Tao Wang	Antiviral azaindole derivatives
EP1132389A1 (en)	2000-03-06	2001-09-12	Vernalis Research Limited	New aza-indolyl derivatives for the treatment of obesity
WO2001083472A1 (en)	2000-04-28	2001-11-08	Acadia Pharmaceuticals, Inc.	Muscarinic agonists
JP2004501092A (ja)	2000-04-28	2004-01-15	バクスター　ヘルスケア　ソシエテ　アノニム	２−アシル−インドール誘導体および抗腫瘍剤としてのその使用
AU2001284823B2 (en)	2000-08-14	2006-11-30	Ortho-Mcneil Pharmaceutical, Inc.	Substituted pyrazoles
US7332494B2 (en)	2000-08-14	2008-02-19	Janssen Pharmaceutica, N.V.	Method for treating allergies using substituted pyrazoles
US7342016B2 (en)	2000-08-30	2008-03-11	Schering Corporation	Farnesyl protein transferase inhibitors as antitumor agents
US6369032B1 (en)	2000-09-06	2002-04-09	Ortho-Mcneil Pharmaceutical, Inc.	Method for treating allergies
CN1321641C (zh)	2000-09-06	2007-06-20	奥索-麦克尼尔药品公司	取代的吡唑在制备用于治疗变态反应的药物中的应用
CA2424222A1 (en)	2000-10-02	2002-04-11	Merck & Co., Inc.	Inhibitors of prenyl-protein transferase
US6958358B2 (en)	2001-01-17	2005-10-25	Amura Therapeutics Limited	Inhibitors of cruzipain and other cysteine proteases
US20030069266A1 (en)	2001-02-02	2003-04-10	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20030207910A1 (en)	2001-02-02	2003-11-06	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
WO2002072549A1 (en)	2001-03-12	2002-09-19	Millennium Pharmaceuticals, Inc.	Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
US6716840B2 (en)	2001-04-09	2004-04-06	Chiron Corporation	Guanidino compounds
DE60217669D1 (de)	2001-05-14	2007-03-08	Bristol Myers Squibb Co	Substitutierte pyrazinone, pyridine und pyrimidine als corticotropin-releasing-factor liganden
AR035543A1 (es)	2001-06-26	2004-06-16	Japan Tobacco Inc	Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
WO2003009852A1 (en)	2001-07-24	2003-02-06	Merck & Co., Inc.	Tyrosine kinase inhibitors
DE10143079A1 (de)	2001-09-03	2003-05-15	Zentaris Ag	Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel
AU2002336462A1 (en)	2001-09-06	2003-03-24	Millennium Pharmaceuticals, Inc.	Piperazine and homopiperazine compounds
ATE348828T1 (de)	2001-10-19	2007-01-15	Transtech Pharma Inc	Beta-carbolin-derivate als ptp-inhibitoren
DE10152306A1 (de)	2001-10-26	2003-07-24	Asta Medica Ag	2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
TW200301251A (en)	2001-12-20	2003-07-01	Wyeth Corp	Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
US20030236277A1 (en)	2002-02-14	2003-12-25	Kadow John F.	Indole, azaindole and related heterocyclic pyrrolidine derivatives
EP1497291B1 (en)	2002-03-27	2006-11-22	Glaxo Group Limited	Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
AU2003224257A1 (en)	2002-04-09	2003-10-27	Astex Technology Limited	Heterocyclic compounds and their use as modulators of p38 map kinase
US20040063744A1 (en)	2002-05-28	2004-04-01	Tao Wang	Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
UA78999C2 (en)	2002-06-04	2007-05-10	Wyeth Corp	1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
US6900206B2 (en)	2002-06-20	2005-05-31	Bristol-Myers Squibb Company	Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
TW200403243A (en)	2002-07-18	2004-03-01	Wyeth Corp	1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
ATE323702T1 (de)	2002-08-06	2006-05-15	Astrazeneca Ab	Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
US20060247261A1 (en)	2002-08-21	2006-11-02	Eatherton Andrew J	Pyrimidine compounds
GB0222493D0 (en)	2002-09-27	2002-11-06	Glaxo Group Ltd	Compounds
JP2006505537A (ja)	2002-09-30	2006-02-16	ジェネラブステクノロジーズ，インコーポレイテッド	Ｃ型肝炎ウイルスの感染を治療するためのヌクレオシド誘導体
FR2845388B1 (fr)	2002-10-08	2004-11-12	Sanofi Synthelabo	Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
AU2004213375A1 (en)	2003-02-14	2004-09-02	Wyeth	Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-Hydroxytryptamine-6 ligands
US20040214856A1 (en)	2003-04-23	2004-10-28	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
PL1753764T3 (pl)	2004-06-09	2009-04-30	Glaxo Group Ltd	Pochodne pirolopirydyny

2005
- 2005-06-07 PL PL05747418T patent/PL1753764T3/pl unknown
- 2005-06-07 DK DK05747418T patent/DK1753764T3/da active
- 2005-06-07 KR KR1020077000449A patent/KR20070034049A/ko not_active Withdrawn
- 2005-06-07 CA CA002569887A patent/CA2569887A1/en not_active Abandoned
- 2005-06-07 TW TW094118669A patent/TW200611695A/zh unknown
- 2005-06-07 US US11/570,099 patent/US7589206B2/en not_active Expired - Fee Related
- 2005-06-07 MX MXPA06014471A patent/MXPA06014471A/es unknown
- 2005-06-07 SI SI200530497T patent/SI1753764T1/sl unknown
- 2005-06-07 WO PCT/EP2005/006182 patent/WO2005121140A1/en not_active Ceased
- 2005-06-07 AR ARP050102327A patent/AR050158A1/es unknown
- 2005-06-07 ES ES05747418T patent/ES2317244T3/es not_active Expired - Lifetime
- 2005-06-07 PT PT05747418T patent/PT1753764E/pt unknown
- 2005-06-07 EP EP05747418A patent/EP1753764B1/en not_active Expired - Lifetime
- 2005-06-07 JP JP2007526300A patent/JP2008501758A/ja not_active Withdrawn
- 2005-06-07 PE PE2005000651A patent/PE20060430A1/es not_active Application Discontinuation
- 2005-06-07 AU AU2005251913A patent/AU2005251913A1/en not_active Abandoned
- 2005-06-07 DE DE602005010698T patent/DE602005010698D1/de not_active Expired - Lifetime
- 2005-06-07 RU RU2006147278/04A patent/RU2006147278A/ru not_active Application Discontinuation
- 2005-06-07 HR HR20090034T patent/HRP20090034T3/xx unknown
- 2005-06-07 UY UY28945A patent/UY28945A1/es unknown
- 2005-06-07 AT AT05747418T patent/ATE412651T1/de not_active IP Right Cessation
- 2005-06-07 BR BRPI0511874-3A patent/BRPI0511874A/pt not_active IP Right Cessation
2006
- 2006-11-27 IL IL179603A patent/IL179603A0/en unknown
- 2006-12-28 MA MA29569A patent/MA28686B1/fr unknown
2007
- 2007-01-04 NO NO20070067A patent/NO20070067L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20070219229A1 (en)	2007-09-20
AU2005251913A1 (en)	2005-12-22
PE20060430A1 (es)	2006-05-25
TW200611695A (en)	2006-04-16
CA2569887A1 (en)	2005-12-22
KR20070034049A (ko)	2007-03-27
PT1753764E (pt)	2009-01-28
DE602005010698D1 (de)	2008-12-11
EP1753764A1 (en)	2007-02-21
HRP20090034T3 (en)	2009-03-31
MXPA06014471A (es)	2007-03-21
US7589206B2 (en)	2009-09-15
DK1753764T3 (da)	2009-02-16
HK1104175A1 (en)	2008-01-04
NO20070067L (no)	2007-02-09
ES2317244T3 (es)	2009-04-16
UY28945A1 (es)	2006-01-31
IL179603A0 (en)	2007-05-15
EP1753764B1 (en)	2008-10-29
AR050158A1 (es)	2006-10-04
ATE412651T1 (de)	2008-11-15
BRPI0511874A (pt)	2008-01-15
JP2008501758A (ja)	2008-01-24
RU2006147278A (ru)	2008-07-20
SI1753764T1 (sl)	2009-02-28
MA28686B1 (fr)	2007-06-01
WO2005121140A1 (en)	2005-12-22

Publication	Publication Date	Title
TWI369356B (en)	2012-08-01	Tetrahydropyridoindole derivatives
IL180481A0 (en)	2007-06-03	Aryl-pyridine derivatives
IL180331A0 (en)	2007-07-04	3-carbamoyl - 2 - pyridone derivative
ZA200610102B (en)	2008-08-27	Pyrrazolo-pyrimidine derivatives
IL182585A0 (en)	2007-07-24	Imidazo-benzodiazepine derivatives
IL183140A0 (en)	2007-09-20	Substituted benzoquinolizine derivatives
IL179603A0 (en)	2007-05-15	Pyrrolopyridine derivatives
IL183142A0 (en)	2007-09-20	New pyridothienopyrimidine derivatives
AP2074A (en)	2009-12-14	New 4-benzylidene-piperidin derivatives
IL183141A0 (en)	2007-09-20	New pyridothienopyrimidine derivatives
ZA200702066B (en)	2008-08-27	Halogenated benzmide derivatives
GB0414272D0 (en)	2004-07-28	OsK1 derivatives
IL177204A0 (en)	2006-12-10	Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives
IL179444A0 (en)	2007-05-15	4-phenyl-pyrimidine-2-carbonitrile derivatives
TWI346109B (en)	2011-08-01	4-amino-5-cyanopyrimidine derivatives
IL182001A0 (en)	2007-07-04	2-acylaminothiazole derivatives
IL178774A0 (en)	2007-02-11	Imidazopyridine compound
ZA200609864B (en)	2008-08-27	Pyrrolopyridine derivatives
GB0422398D0 (en)	2004-11-10	Pyridopyrimidine derivatives
GB0422397D0 (en)	2004-11-10	3-Cyano-Quinoline derivatives
GB0405905D0 (en)	2004-04-21	Azaquinazoline derivatives
GB0422395D0 (en)	2004-11-10	Pyrimidopyrimidine derivatives
HUP0402371A2 (en)	2006-09-28	Novel 125-i-labeled amino-quinoline derivatives
GB0411078D0 (en)	2004-06-23	Bicyclic derivatives
PL367010A1 (pl)	2005-10-17	Preparat przeciwrecesyjny